527 related articles for article (PubMed ID: 21431241)
1. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
[TBL] [Abstract][Full Text] [Related]
2. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.
Sato N; Takeda S; Uchio-Yamada K; Ueda H; Fujisawa T; Rakugi H; Morishita R
Curr Aging Sci; 2011 Jul; 4(2):118-27. PubMed ID: 21235496
[TBL] [Abstract][Full Text] [Related]
3. Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.
Patel AN; Jhamandas JH
Expert Rev Mol Med; 2012 Jan; 14():e2. PubMed ID: 22261393
[TBL] [Abstract][Full Text] [Related]
4. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner Z
Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
[TBL] [Abstract][Full Text] [Related]
5. [Pathological interaction between diabetes mellitus and Alzheimer's disease].
Takeda S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):239-44. PubMed ID: 23373309
[TBL] [Abstract][Full Text] [Related]
6. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
Gupta A; Bisht B; Dey CS
Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
Lin F; Jia J; Qin W
Neuroreport; 2014 Nov; 25(16):1289-95. PubMed ID: 25202927
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
[TBL] [Abstract][Full Text] [Related]
9. Peripheral insulin and brain structure in early Alzheimer disease.
Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
[TBL] [Abstract][Full Text] [Related]
10. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
[TBL] [Abstract][Full Text] [Related]
11. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7036-41. PubMed ID: 20231468
[TBL] [Abstract][Full Text] [Related]
12. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
15. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
Kojro E; Postina R
J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
[TBL] [Abstract][Full Text] [Related]
16. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
17. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
Schmitt HP
Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
[TBL] [Abstract][Full Text] [Related]
18. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
20. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.
Takeuchi M; Yamagishi S
J Alzheimers Dis; 2009; 16(4):845-58. PubMed ID: 19387117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
